Evidence map›Paper›PMID 23835334›Full record

ArticleDiabetes2013

Skeletal muscle triacylglycerol hydrolysis does not influence metabolic complications of obesity.

Mitch T Sitnick, Mahesh K Basantani, Lingzhi Cai, Gabriele Schoiswohl, Cynthia F Yazbeck, Giovanna Distefano, Vladimir Ritov, James P DeLany, Renate Schreiber, Donna B Stolz and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 75 citations in OpenAlex.

  1. Trial
  2. Loss of FoxO in skeletal muscle leads to disrupted muscle metabolism and exacerbates starvation-induced hepatic steatosis.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Wnt Activation in Mature Dermal Adipocytes Leads to Lipodystrophy and Skin Fibrosis via ATGL-Dependent Lipolysis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Muscle Lipid Droplets: Cellular Signaling to Exercise Physiology and Beyond.Trends in endocrinology and metabolism: TEM · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 3 countries.

Mitch T SitnickDivision of Endocrinology, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Mahesh K Basantani
Lingzhi Cai
Gabriele Schoiswohl
Cynthia F Yazbeck
Giovanna Distefano
Vladimir Ritov
James P DeLany
Renate Schreiber
Donna B Stolz
Noah P Gardner
Petra C Kienesberger
Thomas Pulinilkunnil
Rudolf Zechner
Bret H Goodpaster
Paul Coen
Erin E Kershaw
University of Pittsburgh · USDalhousie University · CABoston Biomedical Research Institute · USUniversity of Graz · AT

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND N. DUBOIS · 2009 to 2026
$42.7M
THE ROLE OF LACTOSYLCERAMIDE IN RENAL AGING AND DISEASEP20RR017677 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI SISKIND, LEAH J · 2002 to 2011
$23.4M
T32 Research Training in Diabetes and EndocrinologyT32DK007052 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ROBERT M O'DOHERTY · 1986 to 2026
$6.3M
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTIONC06RR018823 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND, JOHN R · 2003 to 2003
$2.9M
Adipose Triglyceride Lipase (ATGL) in Lipotoxicity and The Metabolic SyndromeR01DK090166 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KERSHAW, ERIN E. · 2011 to 2015
$1.7M
Contribution of ATGL in skeletal muscle to lipid metabolism and insulin actionR03DK077697 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KERSHAW, ERIN E. · 2007 to 2008
$161k
Howard Hughes Medical InstituteNCI NIH HHS P30 CA138313NCI NIH HHS P30-CA-138313NCRR NIH HHS C06 RR018823NCRR NIH HHS C06-RR-018823NCRR NIH HHS P20 RR017677NCRR NIH HHS P20-RR-017677NIDDK NIH HHS R01 DK090166NIDDK NIH HHS R01-DK-090166NIDDK NIH HHS R03 DK077697NIDDK NIH HHS R03-DK-077697NIDDK NIH HHS T32 DK007052
6 · The paper itself

Abstract

Intramyocellular triacylglycerol (IMTG) accumulation is highly associated with insulin resistance and metabolic complications of obesity (lipotoxicity), whereas comparable IMTG accumulation in endurance-trained athletes is associated with insulin sensitivity (the athlete's paradox). Despite these findings, it remains unclear whether changes in IMTG accumulation and metabolism per se influence muscle-specific and systemic metabolic homeostasis and insulin responsiveness. By mediating the rate-limiting step in triacylglycerol hydrolysis, adipose triglyceride lipase (ATGL) has been proposed to influence the storage/production of deleterious as well as essential lipid metabolites. However, the physiological relevance of ATGL-mediated triacylglycerol hydrolysis in skeletal muscle remains unknown. To determine the contribution of IMTG hydrolysis to tissue-specific and systemic metabolic phenotypes in the context of obesity, we generated mice with targeted deletion or transgenic overexpression of ATGL exclusively in skeletal muscle. Despite dramatic changes in IMTG content on both chow and high-fat diets, modulation of ATGL-mediated IMTG hydrolysis did not significantly influence systemic energy, lipid, or glucose homeostasis, nor did it influence insulin responsiveness or mitochondrial function. These data argue against a role for altered IMTG accumulation and lipolysis in muscle insulin resistance and metabolic complications of obesity.

Indexed as

Insulin ResistanceAdipose TissueAnimalsDiet, High-FatEnergy MetabolismHomeostasisHydrolysisIntracellular Signaling Peptides and ProteinsLipid MetabolismMiceMice, KnockoutMice, TransgenicMuscle, SkeletalObesityPhenotypePhosphorylationIntracellular Signaling Peptides and ProteinsTriglycerides

Identifiers

PMID23835334
PMCPMC3781480
OpenAlexW2120674013

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.